Theranexus (EPA:ALTHX) | WebDisclosure

BRIEF

published on 11/10/2026 at 18:05, 1 day 4 hours ago

Positive half-year results for Theranexus' liquidity contract

Liquidity Contract PORTZAMPARC Biopharma Theranexus Securities Purchased
BRIEF

published on 11/10/2026 at 18:05, 1 day 4 hours ago

Bilan semestriel positif pour le contrat de liquidité de Theranexus

Contrat De Liquidité PORTZAMPARC Biopharma Theranexus Titres Achetés
PRESS RELEASE

published on 11/10/2026 at 18:00, 1 day 4 hours ago

BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
BRIEF

published on 10/22/2026 at 18:05, 20 days 4 hours ago

THX Pharma dévoile sa situation financière pour le troisième trimestre 2026.

Essai De Phase 3 Batten-1 Brevet Européen THX Pharma Position De Trésorerie
BRIEF

published on 10/22/2026 at 18:05, 20 days 4 hours ago

THX Pharma: Position de Trésorerie et Avancées Clés au 30 Septembre 2026

Brevet Européen Chiffre D'affaires 2026 Trésorerie THX Pharma Étude Batten-1 Biocodex Partenariat
BRIEF

published on 10/22/2026 at 18:05, 20 days 4 hours ago

THX Pharma Reveals Q3 2026 Financial Status

Cash Position Phase 3 Trial Batten-1 European Patent THX Pharma
BRIEF

published on 10/22/2026 at 18:05, 20 days 4 hours ago

THX Pharma: Cash Position and Key Advances as of September 30, 2026

European Patent Revenue 2026 Biocodex Partnership THX Pharma Treasury Batten-1 Study
PRESS RELEASE

published on 10/22/2026 at 18:00, 20 days 4 hours ago

THX Pharma publie sa position de trésorerie au 30 septembre 2026
THX Pharma publie sa position de trésorerie au 30 septembre 2026, avec une trésorerie disponible de 16,0 M€. Faits marquants : dépôt des demandes d'autorisation pour l'essai pivot de Batten-1 et brevet européen délivré jusqu'en 2041

Trésorerie Batten-1 Brevet Européen THX Pharma Dépôt Des Demandes
PRESS RELEASE

published on 10/22/2026 at 18:00, 20 days 4 hours ago

THX Pharma Reports Its Cash Position as of September 30, 2026
THX Pharma announces cash position as of September 30, 2026. Cash and cash equivalents at €16.0 million. Highlights include Batten-1 Phase 3 trial submission, European patent grant, and revenue growth

Revenue Growth Cash Position Batten-1 THX Pharma Phase 3 Trial Submission
BRIEF

published on 09/29/2026 at 18:05, 1 month 12 days ago

THX Pharma Publie ses Résultats du Premier Semestre 2026

Résultats Semestriels Batten-1 Maladies Neurologiques Rares THX Pharma Accord Biocodex

Published on 11/11/2026 at 19:31, 2 hours 48 minutes ago

Lion Copper Corp. Completes S-K 1300 Technical Report Summary for Bear Copper Deposit
Published on 11/11/2026 at 16:30, 5 hours 49 minutes ago

ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
Published on 11/11/2026 at 14:25, 7 hours 54 minutes ago

Route1 Announces 2026 Annual Meeting Results
Published on 11/11/2026 at 14:00, 8 hours 19 minutes ago

PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
Published on 11/11/2026 at 14:00, 8 hours 19 minutes ago

NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers

View all ACCESSWIRE

Published on 11/11/2026 at 19:29, 2 hours 50 minutes ago

EQS-Adhoc: Allianz SE: Allianz delivers record nine-month result of 14.1 billion euros and raises 2026 outlook
Published on 11/11/2026 at 18:41, 3 hours 37 minutes ago

AUSTRIACARD HOLDINGS AG: 9M 2026 Financial Results
Published on 11/11/2026 at 18:37, 3 hours 42 minutes ago

Holding(s) in Company
Published on 11/11/2026 at 18:36, 3 hours 43 minutes ago

Holding(s) in Company
Published on 11/11/2026 at 18:35, 3 hours 44 minutes ago

Holding(s) in Company

View all EQS

Published on 11/10/2026 at 18:00, 1 day 4 hours ago

Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 1 day 4 hours ago

Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:40, 1 day 4 hours ago

Production du 3ième trimestre 2026
Published on 11/10/2026 at 17:35, 1 day 4 hours ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 1 day 4 hours ago

CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.

View all LES ECHOS COMFI WIRE

News